https://doi.org/10.4081/reumatismo.2024.1681
Acute heart failure due to myocarditis in Takayasu's arteritis
Submitted: 8 November 2023
Accepted: 16 April 2024
Published: 24 September 2024
Accepted: 16 April 2024
Abstract Views: 517
PDF: 86
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Takayasu’s arteritis (TA) is a granulomatous vasculitis that involves the aortic artery and its branches, resulting in stenosis, occlusion, and aneurysmal dilatation. Cardiovascular involvement is one of the main complications and a major cause of mortality in these patients. Herein, we describe the case of a woman with TA who presented with severe acute heart failure secondary to myocarditis and responded well to immunosuppressive therapy.
Kerr GS. Takayasu arteritis. Ann Intern Med 1994; 120: 919-29.
DOI: https://doi.org/10.7326/0003-4819-120-11-199406010-00004
Chen B, Wang X, Yin W, Gao Y, Hou Z, An Y, et al. Assessment of disease activity in Takayasu arteritis: A quantitative study with computed tomography angiography. Int J Cardiol 2019; 289: 144-9.
DOI: https://doi.org/10.1016/j.ijcard.2019.04.086
Goel R, Chandan JS, Thayakaran R, Adderley NJ, Nirantharakumar K, Harper L. Cardiovascular and renal morbidity in Takayasu arteritis: a population‐based retrospective cohort study from the United Kingdom. Arthritis Rheumatol 2021; 73: 504-11.
DOI: https://doi.org/10.1002/art.41529
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of takayasu arteritis. Arthritis Rheum 2010; 33: 1129-34.
DOI: https://doi.org/10.1002/art.1780330811
Kim H, Barra L. Ischemic complications in Takayasu’s arteritis: a meta-analysis. Semin Arthritis Rheum 2018; 47: 900-6.
DOI: https://doi.org/10.1016/j.semarthrit.2017.11.001
Miloslavsky E, Unizony S. The heart in vasculitis. Rheum Dis Clin North Am 2014; 40: 11-26.
DOI: https://doi.org/10.1016/j.rdc.2013.10.006
Talwar KK, Kumar K, Chopra P, Sharma S, Shrivastava S, Wasir HS, et al. Cardiac involvement in nonspecific aortoarteritis (Takayasu’s arteritis). Am Heart J 1991; 122: 1666-70.
DOI: https://doi.org/10.1016/0002-8703(91)90285-P
Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart 2014; 100: 1673-80.
DOI: https://doi.org/10.1136/heartjnl-2014-305538
Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 2015; 16: 1-11.
DOI: https://doi.org/10.1093/ehjci/jeu184
Takeda N, Takahashi T, Seko Y, Maemura K, Nakasone H, Sakamoto K, et al. Takayasu myocarditis mediated by cytotoxic T lymphocytes. Intern Med 2005;44:256-60.
DOI: https://doi.org/10.2169/internalmedicine.44.256
An X, Han Y, Zhang B, Qiao L, Zhao Y, Guo X, et al. Takayasu arteritis presented with acute heart failure: case report and review of literature. ESC Heart Fail 2017; 4: 649-54.
DOI: https://doi.org/10.1002/ehf2.12174
How to Cite
Castro de Oliveira Figueirôa, M., Moura Costa, M., Rocha Lobo, P., Souza Pedreira, A., & Barreto Santiago, M. (2024). Acute heart failure due to myocarditis in Takayasu’s arteritis. Reumatismo. https://doi.org/10.4081/reumatismo.2024.1681
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- W. Grassi, C. Montecucco, Approved indications and other possible utilizations of anti-TNFa biologic drugs , Reumatismo: Vol. 57 No. s4 (2005)
- C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi, Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis , Reumatismo: Vol. 59 No. 1 (2007)
- A. Rebora, CONVENTIONAL THERAPIES FOR PSORIASIS , Reumatismo: Vol. 59 No. s1 (2007)
- S. Zingarelli, P. Airò, M. Frassi, C. Bazzani, M. Scarsi, M. Puoti, Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases , Reumatismo: Vol. 60 No. 1 (2008)
- R. Ramírez-Sandoval, M. Vázquez-del-Mercado, A. Daneri-Navarro, E. López-Robles, J.J. Bollain-y-Goitia, E. Avalos-Diaz, R. Herrera-Esparza, Intracellular antigens released from Balb/c mice kidneys under chemically induced apoptosis and/or necrosis , Reumatismo: Vol. 60 No. 2 (2008)
- D.J. Manzella, L. Vicente, A.A. Pérez de la Hoz, R.J. Zamora, G. De Rosa, A.A. Pisarevsky, Catastrophic antiphospholipid syndrome as a complication of systemic sclerosis , Reumatismo: Vol. 71 No. 2 (2019)
- A. Lurati, R. Cimaz, M. Gattinara, V. Gerloni, B. Teruzzi, A. Salmaso, F. Fantini, Relationship between delayed menarche and bone density in patients affected by juvenile , Reumatismo: Vol. 60 No. 3 (2008)
- G. Cuomo, G. Abignano, L. Ruocco, S. Vettori, G. Valentini, Hypocomplementemia in systemic sclerosis , Reumatismo: Vol. 60 No. 4 (2008)
- M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi, Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis , Reumatismo: Vol. 61 No. 1 (2009)
- T.L. Skare, A.C. Schönrock, Clinical profile of patients with lupus nephritis , Reumatismo: Vol. 61 No. 4 (2009)
You may also start an advanced similarity search for this article.
